Patents by Inventor Ricky Wayne Johnstone

Ricky Wayne Johnstone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY OF BROMODOMAIN INHIBITORS AND CHECKPOINT BLOCKADE
    Publication number: 20190192532
    Abstract: The present disclosure provides combination therapy of a bromodomain inhibitor and an immune modulator (e.g., an immune check point inhibitor). The combination of the bromodomain inhibitor and the immune modulator may be useful in treating or preventing cancer in a subject. In certain embodiments, the subject has an intact immune system. The combination of the bromodomain inhibitor and the immune modulator is expected to be synergistic.
    Type: Application
    Filed: September 30, 2016
    Publication date: June 27, 2019
    Inventors: James E. Bradner, Simon John Hogg, Ricky Wayne Johnstone, Jake Shortt
  • Stimulating immune response
    Patent number: 9724329
    Abstract: Methods of treatment or prevention of a cancerous or pre-cancerous condition, of slowing or preventing growth of a cancerous condition, of stimulating a cell-mediated immune response, stimulating a Th1 helper T cell response against a pathogen in a mammal and of treating or preventing inflammatory diseases or disorders that involve administration of N-methyl pyrrolidone (NMP) or a physiologically acceptable salt, solvate, tautomer or prodrug thereof are provided. Also provided are formulations of an active agent.
    Type: Grant
    Filed: June 21, 2011
    Date of Patent: August 8, 2017
    Assignee: Peter MacCallum Cancer Institute
    Inventors: Andy Kang-Wei Hsu, Jake Shortt, Paul Neeson, Ricky Wayne Johnstone, David Ritchie
  • COMBINATION OF HDAC INHIBITORS WITH THROMBOCYTOPENIA DRUGS
    Publication number: 20160199350
    Abstract: The invention relates to a combination which comprises: (a) a HDAC inhibitor; and (b) an anti-thrombocytopenia drug, for simultaneous, concurrent, separate or sequential use, especially for use in the treatment of a proliferative diseases.
    Type: Application
    Filed: November 30, 2015
    Publication date: July 14, 2016
    Inventors: Peter Wisdom Atadja, Ricky Wayne Johnstone, Henry Miles Prince, Mark John Bishton, Simon James Harrison
  • STIMULATING IMMUNE RESPONSE
    Publication number: 20130302377
    Abstract: Methods of treatment or prevention of a cancerous or pre-cancerous condition, of slowing or preventing growth of a cancerous condition, of stimulating a cell-mediated immune response, stimulating a Th1 helper T cell response against a pathogen in a mammal and of treating or preventing inflammatory diseases or disorders that involve administration of N-methyl pyrrolidone (NMP) or a physiologically acceptable salt, solvate, tautomer or prodrug thereof are provided. Also provided are formulations of an active agent.
    Type: Application
    Filed: June 21, 2011
    Publication date: November 14, 2013
    Applicant: PETER MACCALLUM CANCER INSTITUTE
    Inventors: Andy Kang-Wei Hsu, Jake Shortt, Paul Neeson, Ricky Wayne Johnstone, David Ritchie
  • COMBINATION OF HDAC INHIBITORS WITH THROMBOCYTOPENIA DRUGS
    Publication number: 20130171141
    Abstract: The invention relates to a combination which comprises: (a) a HDAC inhibitor; and (b) an anti-thrombocytopenia drug, for simultaneous, concurrent, separate or sequential use, especially for use in the treatment of a proliferative diseases.
    Type: Application
    Filed: August 31, 2011
    Publication date: July 4, 2013
    Applicant: NOVARTIS AG
    Inventors: Peter Wisdom Atadja, Ricky Wayne Johnstone, Henry Miles Prince, Mark John Brishton, Simon James Harrison